773 related articles for article (PubMed ID: 30999647)
21. FJU-C28 inhibits the endotoxin-induced pro-inflammatory cytokines expression via suppressing JNK, p38 MAPK and NF-κB signaling pathways.
Jung F; Liu JS; Yang SH; Tseng HY; Chou SP; Lin JC; Jow GM
Pharmacol Res Perspect; 2021 Dec; 9(6):e00876. PubMed ID: 34669271
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-92a antagonism attenuates lipopolysaccharide (LPS)-induced pulmonary inflammation and injury in mice through suppressing the PTEN/AKT/NF-κB signaling pathway.
Fu L; Zhu P; Qi S; Li C; Zhao K
Biomed Pharmacother; 2018 Nov; 107():703-711. PubMed ID: 30138892
[TBL] [Abstract][Full Text] [Related]
23. Heliangin inhibited lipopolysaccharide-induced inflammation through signaling NF-κB pathway on LPS-induced RAW 264.7 cells.
Lu X; Min L; Wei J; Gou H; Bao Z; Wang J; Wang Z; Huang Y; An B
Biomed Pharmacother; 2017 Apr; 88():102-108. PubMed ID: 28095354
[TBL] [Abstract][Full Text] [Related]
24. Anti-inflammatory action of Athyrium multidentatum extract suppresses the LPS-induced TLR4 signaling pathway.
Han XZ; Ma R; Chen Q; Jin X; Jin YZ; An RB; Piao XM; Lian ML; Quan LH; Jiang J
J Ethnopharmacol; 2018 May; 217():220-227. PubMed ID: 29476961
[TBL] [Abstract][Full Text] [Related]
25. Isorhamnetin protects mice from lipopolysaccharide-induced acute lung injury via the inhibition of inflammatory responses.
Chi G; Zhong W; Liu Y; Lu G; Lü H; Wang D; Sun F
Inflamm Res; 2016 Jan; 65(1):33-41. PubMed ID: 26525359
[TBL] [Abstract][Full Text] [Related]
26. Quercetin disrupts tyrosine-phosphorylated phosphatidylinositol 3-kinase and myeloid differentiation factor-88 association, and inhibits MAPK/AP-1 and IKK/NF-κB-induced inflammatory mediators production in RAW 264.7 cells.
Endale M; Park SC; Kim S; Kim SH; Yang Y; Cho JY; Rhee MH
Immunobiology; 2013 Dec; 218(12):1452-67. PubMed ID: 23735482
[TBL] [Abstract][Full Text] [Related]
27. Farrerol Relieve Lipopolysaccharide (LPS)-Induced Mastitis by Inhibiting AKT/NF-κB p65, ERK1/2 and P38 Signaling Pathway.
Li Y; Gong Q; Guo W; Kan X; Xu D; Ma H; Fu S; Liu J
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29904013
[TBL] [Abstract][Full Text] [Related]
28. p38 Mitogen-activated protein kinase up-regulates LPS-induced NF-kappaB activation in the development of lung injury and RAW 264.7 macrophages.
Kim HJ; Lee HS; Chong YH; Kang JL
Toxicology; 2006 Aug; 225(1):36-47. PubMed ID: 16793190
[TBL] [Abstract][Full Text] [Related]
29. An Active Drimane-Type Lactone from Polygonum jucundum Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice Through TLR4-MAPKs Signaling Pathway.
Hu Y; Tao L; Tan H; Zhang M; Shimizu K; Zhang F; Zhang C
Inflammation; 2017 Aug; 40(4):1204-1213. PubMed ID: 28455603
[TBL] [Abstract][Full Text] [Related]
30. Herbacetin inhibits inducible nitric oxide synthase via JNK and nuclear factor-κB in LPS-stimulated RAW264.7 cells.
Li L; Sapkota M; Kim SW; Soh Y
Eur J Pharmacol; 2015 Oct; 765():115-23. PubMed ID: 26297979
[TBL] [Abstract][Full Text] [Related]
31. Anti-inflammatory activity of atractylenolide III through inhibition of nuclear factor-κB and mitogen-activated protein kinase pathways in mouse macrophages.
Ji GQ; Chen RQ; Wang L
Immunopharmacol Immunotoxicol; 2016; 38(2):98-102. PubMed ID: 26667579
[TBL] [Abstract][Full Text] [Related]
32. β-carotene attenuates lipopolysaccharide-induced inflammation via inhibition of the NF-κB, JAK2/STAT3 and JNK/p38 MAPK signaling pathways in macrophages.
Li R; Hong P; Zheng X
Anim Sci J; 2019 Jan; 90(1):140-148. PubMed ID: 30460722
[TBL] [Abstract][Full Text] [Related]
33. 4-Hydroxy-7-Methoxycoumarin Inhibits Inflammation in LPS-activated RAW264.7 Macrophages by Suppressing NF-κB and MAPK Activation.
Kang JK; Hyun CG
Molecules; 2020 Sep; 25(19):. PubMed ID: 32993156
[TBL] [Abstract][Full Text] [Related]
34. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
[TBL] [Abstract][Full Text] [Related]
35. Fucoxanthin decreases lipopolysaccharide-induced acute lung injury through the inhibition of RhoA activation and the NF-κB pathway.
Lee CY; Chen SP; Huang-Liu R; Gau SY; Li YC; Chen CJ; Chen WY; Wu CN; Kuan YH
Environ Toxicol; 2022 Sep; 37(9):2214-2222. PubMed ID: 35616142
[TBL] [Abstract][Full Text] [Related]
36. Urolithin A attenuates pro-inflammatory mediator production by suppressing PI3-K/Akt/NF-κB and JNK/AP-1 signaling pathways in lipopolysaccharide-stimulated RAW264 macrophages: Possible involvement of NADPH oxidase-derived reactive oxygen species.
Komatsu W; Kishi H; Yagasaki K; Ohhira S
Eur J Pharmacol; 2018 Aug; 833():411-424. PubMed ID: 29932926
[TBL] [Abstract][Full Text] [Related]
37. Oridonin protects LPS-induced acute lung injury by modulating Nrf2-mediated oxidative stress and Nrf2-independent NLRP3 and NF-κB pathways.
Yang H; Lv H; Li H; Ci X; Peng L
Cell Commun Signal; 2019 Jun; 17(1):62. PubMed ID: 31186013
[TBL] [Abstract][Full Text] [Related]
38. Protective effect of sesquiterpene lactone parthenolide on LPS-induced acute lung injury.
Jang YJ; Back MJ; Fu Z; Lee JH; Won JH; Ha HC; Lee HK; Jang JM; Choi JM; Kim DK
Arch Pharm Res; 2016 Dec; 39(12):1716-1725. PubMed ID: 27757770
[TBL] [Abstract][Full Text] [Related]
39. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
[TBL] [Abstract][Full Text] [Related]
40. Atractylenolide I protects mice from lipopolysaccharide-induced acute lung injury.
Zhang JL; Huang WM; Zeng QY
Eur J Pharmacol; 2015 Oct; 765():94-9. PubMed ID: 26297303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
